How will our Pharmacy practice cope with the new falsified medicine directive?

The new falsified medicine directive aims to stem the rise in counterfeit medicines in the supply chain and in addition enable swift recalls of medicines to  patient level , if required. Current practices of snipping two tables off 30 pack  tablets when the prescription calls for just “28” will have to  be addressed as each dispensed pack is to  have its own unique identifier. Pharmacies will have to be able to recall medicines from the patients and may  have to scan medicines at the point of dispensing to like the medicine with the patient. The effect of this will  inevitable incur extra costs and time and will impact on waiting times. It is hoped that minutia of the legislation will  be announced later in the year. Who will  fund the technology that may  be necessary to  upgrade some pharmacy and wholesaling systems and will the customers understand why they have to wait longer ? But more importantly  will the prescriber  start to dispense in whole packs ? Will patients end up with more unused medicines at  home or will they become synchronised?